M Nishikawa, M Nagata, M Takeda, T Sato, T Sanaka, N Sugino
{"title":"环孢素对(NZB x NZW)F1小鼠肾脏组织病理学的影响。","authors":"M Nishikawa, M Nagata, M Takeda, T Sato, T Sanaka, N Sugino","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Ciclosporin A (CYA) is a newly developed immunosuppressant and has a sparing effect on suppressor cell regulatory mechanism. However, accumulation of experimental animal studies has not been enough for the administration of CYA to human autoimmune diseases such as lupus nephritis. In this study, the histopathological aspects of the kidney in (NZB x NZW)F1 mice after administration of CYA were analysed. A dose of 25 mg/kg/day of CYA was injected intraperitoneally so that serum level of CYA was controlled from 250 to 300 ng/ml with this dosage. Typical histopathological changes of lupus nephritis including wire-loop lesions were observed in the kidney of the non-treated control group. In contrast, only few lesions were demonstrated in the CYA-treated group. These results suggest that CYA prevented the renal deterioration in lupus mice.</p>","PeriodicalId":22530,"journal":{"name":"The Japanese journal of experimental medicine","volume":"59 4","pages":"167-72"},"PeriodicalIF":0.0000,"publicationDate":"1989-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effects of ciclosporin on the renal histopathological aspects in (NZB x NZW)F1 mice.\",\"authors\":\"M Nishikawa, M Nagata, M Takeda, T Sato, T Sanaka, N Sugino\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ciclosporin A (CYA) is a newly developed immunosuppressant and has a sparing effect on suppressor cell regulatory mechanism. However, accumulation of experimental animal studies has not been enough for the administration of CYA to human autoimmune diseases such as lupus nephritis. In this study, the histopathological aspects of the kidney in (NZB x NZW)F1 mice after administration of CYA were analysed. A dose of 25 mg/kg/day of CYA was injected intraperitoneally so that serum level of CYA was controlled from 250 to 300 ng/ml with this dosage. Typical histopathological changes of lupus nephritis including wire-loop lesions were observed in the kidney of the non-treated control group. In contrast, only few lesions were demonstrated in the CYA-treated group. These results suggest that CYA prevented the renal deterioration in lupus mice.</p>\",\"PeriodicalId\":22530,\"journal\":{\"name\":\"The Japanese journal of experimental medicine\",\"volume\":\"59 4\",\"pages\":\"167-72\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Japanese journal of experimental medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese journal of experimental medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
环孢素A (cyclosporin A, CYA)是一种新开发的免疫抑制剂,对抑制细胞的调控机制有一定的保护作用。然而,实验动物研究的积累还不足以证明CYA治疗人类自身免疫性疾病,如狼疮肾炎。本研究分析了CYA给药后(NZB x NZW)F1小鼠肾脏的组织病理学变化。腹腔注射25 mg/kg/天的CYA,使血清CYA水平控制在250 ~ 300 ng/ml。在未治疗的对照组中观察到典型的狼疮性肾炎的组织病理学改变,包括肾袢病变。相比之下,cya治疗组仅出现少量病变。这些结果表明,CYA可预防狼疮小鼠肾脏恶化。
The effects of ciclosporin on the renal histopathological aspects in (NZB x NZW)F1 mice.
Ciclosporin A (CYA) is a newly developed immunosuppressant and has a sparing effect on suppressor cell regulatory mechanism. However, accumulation of experimental animal studies has not been enough for the administration of CYA to human autoimmune diseases such as lupus nephritis. In this study, the histopathological aspects of the kidney in (NZB x NZW)F1 mice after administration of CYA were analysed. A dose of 25 mg/kg/day of CYA was injected intraperitoneally so that serum level of CYA was controlled from 250 to 300 ng/ml with this dosage. Typical histopathological changes of lupus nephritis including wire-loop lesions were observed in the kidney of the non-treated control group. In contrast, only few lesions were demonstrated in the CYA-treated group. These results suggest that CYA prevented the renal deterioration in lupus mice.